Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Naranjo

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 5, 2022
Competent Cell Preparation and Transformation of Pichia pastorisJoan Lin-Cereghino, Christopher A Naranjo, Geoff P Lin-Cereghino
Microbial Cell Factories|September 5, 2022
Steric accessibility of the N-terminus improves the titer and quality of recombinant proteins secreted from Komagataella phaffiiNeil C Dalvie, Christopher A Naranjo, Sergio A Rodriguez-Aponte, et al.
Biotechnology and Bioengineering|March 17, 2023
Minimal purification method enables developability assessment of recombinant proteinsSergio A Rodriguez-Aponte, Christopher A Naranjo, Ryan S Johnston, et al.
Biotechnology and Bioengineering|November 15, 2024
Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffiiYuchen Yang, Neil C Dalvie, Joseph R Brady, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
An intravenous DNA-binding priming agent protects cell-free DNA and improves the sensitivity of liquid biopsiesShervin Tabrizi, Carmen Martin-Alonso, Kan Xiong, et al.
Biotechnology and Bioengineering|November 15, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffiiNeil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>Neil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Human Vaccines & Immunotherapeutics|June 6, 2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsSakshi Bajoria, Kawaljit Kaur, Ozan S Kumru, et al.
Science (New York, N.Y.)|January 18, 2024
Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsiesCarmen Martin-Alonso, Shervin Tabrizi, Kan Xiong, et al.
Applied and Environmental Microbiology|October 6, 2019
Role of <i>BGS13</i> in the Secretory Mechanism of Pichia pastorisChristopher A Naranjo, Anita D Jivan, Maria N Vo, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|July 5, 2022
Competent Cell Preparation and Transformation of Pichia pastorisJoan Lin-Cereghino, Christopher A Naranjo, Geoff P Lin-Cereghino
Microbial Cell Factories|September 5, 2022
Steric accessibility of the N-terminus improves the titer and quality of recombinant proteins secreted from Komagataella phaffiiNeil C Dalvie, Christopher A Naranjo, Sergio A Rodriguez-Aponte, et al.
Biotechnology and Bioengineering|March 17, 2023
Minimal purification method enables developability assessment of recombinant proteinsSergio A Rodriguez-Aponte, Christopher A Naranjo, Ryan S Johnston, et al.
Biotechnology and Bioengineering|November 15, 2024
Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffiiYuchen Yang, Neil C Dalvie, Joseph R Brady, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
An intravenous DNA-binding priming agent protects cell-free DNA and improves the sensitivity of liquid biopsiesShervin Tabrizi, Carmen Martin-Alonso, Kan Xiong, et al.
Biotechnology and Bioengineering|November 15, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffiiNeil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>Neil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Human Vaccines & Immunotherapeutics|June 6, 2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsSakshi Bajoria, Kawaljit Kaur, Ozan S Kumru, et al.
Science (New York, N.Y.)|January 18, 2024
Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsiesCarmen Martin-Alonso, Shervin Tabrizi, Kan Xiong, et al.
Applied and Environmental Microbiology|October 6, 2019
Role of <i>BGS13</i> in the Secretory Mechanism of Pichia pastorisChristopher A Naranjo, Anita D Jivan, Maria N Vo, et al.
Pageof 2